A Phase I Study of Docetaxel and Bexarotene

Publisher： Karger

E-ISSN： 1421-9794|54|2|125-130

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.2, 2008-03, pp. : 125-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Bexarotene and Rosiglitazone in Patients with Refractory Cancers

By  

Chemotherapy, Vol. 54, Iss. 3, 2008-06 ,pp. : 236-241

Karger

Access to resources Recommend Favorite

A Phase II Study of Docetaxel and Oxaliplatin for Second-Line Treatment of Urothelial Carcinoma

By  

Chemotherapy, Vol. 55, Iss. 5, 2009-07 ,pp. : 321-326

Karger

Access to resources Recommend Favorite

Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma

By  

Chemotherapy, Vol. 50, Iss. 6, 2004-12 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

A Phase II Study of Docetaxel and Infusional Cisplatin in Advanced Non-Small-Cell Lung Cancer

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 120-125

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 126-131

Karger

Access to resources Recommend Favorite